reviewFEBS JournalJan 17, 2012Closed access

Quinolinic acid, the inescapable neurotoxin

UNSW Sydney · St Vincent's Hospital Sydney

PubMed
Indexed incrossrefpubmed

Abstract

Over the last two decades, evidence for the involvement of quinolinic acid (QUIN) in neuroinflammatory diseases has been exponentially increasing. Within the brain, QUIN is produced and released by infiltrating macrophages and activated microglia, the very cells that are prominent during neuroinflammation. QUIN acts as an agonist of the N-methyl-D-aspartate receptor and as such is considered to be a brain endogenous excitotoxin. Since the discovery of the excitotoxic activity of QUIN in the early 1980s, several other cytotoxic mechanisms have been identified. We know today that QUIN acts as a neurotoxin, gliotoxin, proinflammatory mediator, pro-oxidant molecule and can alter the integrity and cohesion of the…

Citation impact

600
total citations
FWCI
14.05
Percentile
100%
References
117
Citations per year

Authors

1

Topics & keywords

Keywords
  • Quinolinic acid
  • Neurotoxin
  • Neuroinflammation
  • Microglia
  • Proinflammatory cytokine
  • Receptor
  • Agonist
  • Gliotoxin
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.